On Jan. 18, 2019, Prinston Pharmaceutical Inc., dba Solco Healthcare LLC., initiated a voluntary recall of one (1) lot of Irbesartan and seven (7) lots of Irbesartan HCTZ Tablets used to treat blood pressure. In standalone and combined forms, valsartan has been a go-to therapy for cardiovascular issues for a generation. By Howard Cohen / Miami Herald Sunday Dec 9, 2018 at 8:31 AM. (CBS) Another pharmaceutical company is recalling blood pressure medication after detecting trace amounts of a cancer-causing chemical. blood pressure medication recall list 2019: blood pressure medication recall list 2018: 12 3. Legacy Pharmaceutical Packaging, LLC is recalling 40 repackaged lots of Losartan Tablets USP 25mg, 50mg, and 100mg to the consumer level. According to fda.gov, as of Feb. 22, 2019: Macleods Pharmaceuticals Limited is voluntarily recalling one lot of Losartan Potassium/Hydrochlorothiazide combination tablets 100mg/25mg to the consumer level due to the detection of trace amounts of an unexpected impurity (NDEA) found in finished product manufactured with active pharmaceutical ingredient made by Hetero Labs Limited. by Kent Allen, AARP, August 7, 2018 | Comments: 0. For a complete list of the recalled medication, click here. Valsartan in combination with Amlodipine or Hydrochlorothiazide is used for the treatment of high blood pressure. By Bloomberg . / Blood Pressure Medication Recall List. Registration on or use of this site constitutes acceptance of our User Agreement, Privacy Policy and Cookie Statement, and Your California Privacy Rights (each updated 1/1/21). The FDA also posted labels of the Teva lots affected. Off-label. Twitter Share. The lots similarly were found to contain N-methylnitrosobutyric acid (NMBA) above the acceptable daily intake levels released by the U.S. Food and Drug Administration … Updated Sep 30, 2019; Posted Sep 30, 2019 . The FDA said in a March 22 posting on its website that it has updated the list of valsartan medicines under recall to incorporate additional repackagers of Aurobindo’s valsartan-containing medicine. An Attorney who has filed 12 high blood pressure medication lawsuits so far, told judges at a conference in the U.S. District Court in New Jersey last month he expected there to be at least 2000 high blood pressure medication lawsuits filed within the next two years. The FDA has said it thinks the potential carcinogens, known as nitrosamine impurities, are a result of the manufacturing processes the companies used. You may have questions, we have answers. The three impurities are chemical compounds in the nitrosamines class and NDEA and NDMA are considered to be a probable cancer-causing risk in humans at certain exposure levels, and NDMA a potential one. Representatives for Aurobindo and Lupin didn't respond to requests for comment. The agency is urging patients to continue taking their medications until a pharmacist or doctor provides another option because they need to balance the risks of out-of-control blood pressure against that of a tiny elevated risk of cancer. Blood pressure medication recall expanded again over potential cancer-causing ingredient. NMBA is a potential human carcinogen. Some of the batches aren’t due to expire until August 2020. The finished products are manufactured by Mylan Pharmaceuticals Inc. and Mylan Laboratories Limited. DMF is cheaper than some other solvents, making it appealing for companies coping with the bruising economics of the generic-drug business. Subscribe to MassLive.com. The company said it hadn't received any reports of patients being harmed related to the recall. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Advance Local. All rights reserved (About Us). Kirk Hessels, a spokesman for Camber, didn't immediately respond to requests for comment on Friday. Note to readers: if you purchase something through one of our affiliate links we may earn a commission. The peripheral adrenergic inhibitors work in the brain to block signals that tell blood vessels to constrict. A number of medications in the class of drugs known as angiotensin II receptor blockers have been under voluntary recall since July because of the detection of unacceptable levels of N-Nitrosodiethylamine (NDEA) and/or N-nitrosodimethylamine (NDMA) and, more recently, N-Nitroso N-Methyl 4-amino butyric acid (NMBA), in their active pharmaceutical ingredient such as losartan and valsartan as well as irbesartan. Next 21 results. Latest blood pressure medication recall list, updated September 2019. You may have recently heard that FDA has recalled several blood pressure medications. 4 questions and answers for consumers about FDA’s recent high blood pressure medication recall. Company Medicine NDC Lot Number Expiration; A-S Medication Solutions LLC (Teva/Actavis & Prinston/Solco) Valsartan 80mg Tablet: 54569-6582-1 : 342B17019: 09/2019: A-S Medication Solutions LLC (Teva/Actavis & Prinston/Solco) Valsartan 80mg Tablet: 54569-6582-1 : 342B17018: 08/2019: A-S Medication Solutions LLC (Teva/Actavis & Prinston/Solco) … Hundreds of lots of the medication have been recalled since last July. The agency said those byproducts would not have been detected in routine inspections because the process depends on scientists knowing which chemical intruders are likely to be accidentally created during the process, knowledge that they said regulators and companies lacked until recently. The Food and Drug Administration (FDA) is issuing a worldwide recall for a blood pressure and heart failure medication that contains an active ingredient linked to an impurity that is a known probable human carcinogen. Camber said in a statement on Thursday that it was recalling 87 lots of losartan tablets due to the discovery. Top Searches Holiday Gifts. See also: sub-topics. » RELATED: Blood pressure medication recalls: Everything you should know, Atlanta doctors, experts say. Here are the 10 lots. Twitter Share. Carton NDC#: 60687-139-01 There was a time when the high blood pressure medication list was very short indeed. To break them down, a solvent like DMF may be used, but it's supposed to largely vanish by the time a pill is put into a bottle for sale. Torrent Pharmaceuticals widened its recall to include 114 additional lots of losartan potassium and losartan potassium/hydrochlorothiazide combination tablets, the … These batches were distributed domestically between March 2017 and November 2018. The U.S. Food and Drug Administration is alerting patients and health care professionals to another recall of medications used to treat high blood pressure and heart failure due to the presence of a potential cancer-causing substance. This recall was prompted due to Camber Pharmaceuticals, Inc. issuing a Voluntary Nationwide Recall of Losartan Tablets, USP, due to the detection of trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) a possible process impurity or contaminant in an active pharmaceutical ingredient, manufactured by Hetero Labs Limited, (API manufacturer). For people with high blood pressure, there’s a range of other approved medications available that may be safer and more effective than alpha-blockers and alpha-2 … Facebook Share. More blood pressure drugs are being recalled after being found to contain trace amounts of a potentially cancer-causing ingredient, one of a slew of recalls of medications to treat hypertension. An online pharmacy told U.S. regulators it found another cancer-causing chemical in widely prescribed blood-pressure pills, raising new questions about a complex global web of companies that produces medicine for millions of people. Yet another blood pressure medication manufacturer is announcing a massive recall of its products due to potentially cancer-causing impurities. She said that drug manufacturers will continue to test their products and recall pills that contain impurities over an interim limit the FDA established to make sure patients can continue to have access to the medications in the short term. The carcinogens are found in smoked and grilled meats. By Bloomberg . The voluntary recall was expanded in December by Mylan to all unexpired lots. . More blood pressure drugs are being recalled after being found to contain trace amounts of a potentially cancer-causing ingredient, one of a slew of recalls of medications to treat hypertension. Need exclusive stories only we can tell? A carcinogen is something that could cause you to have cancer. To date, Camber has not received any reports of adverse events related to this recall. Mylan Pharmaceuticals Inc./Mylan Laboratories Limited. The full list of expanded recalled batches can be viewed at https://www.fda.gov/Safety/Recalls/ucm627647.htm. Camber Pharmaceuticals, Inc. is recalling 87 lots of Losartan Tablets USP 25 mg, 50 mg, and 100 mg to consumer level. STOCK PHOTO/Getty Images. Which blood pressure medication that has the lowest side effects depends on how you react to specific medications and what side effects you find most bothersome. A solvent called dimethylformamide was discovered in the drug valsartan made by several companies, including Swiss pharmaceutical giant Novartis, according to a filing last week to the Food and Drug Administration by New Haven, Connecticut-based Valisure. But the official limit considered "safe" for human consumption brings a much lower risk than the possible exposure from tainted drugs - causing less than one additional case of cancer in 100,000 people over a lifetime. The U.S. Food and Drug Administration is alerting patients and health care professionals to another recall of medications used to treat high blood pressure and heart failure due to the presence of a potential cancer-causing substance. » RELATED: Blood pressure medication recalls: Everything you should know, Atlanta doctors, experts say The drugs, angiotensin II receptor blockers (ARBs), work by widening or … In July, five medications of Valsartan/Hyrdrochlorothiazide blood pressure drugs manufactured by Major Pharmaceuticals, Teva Pharmaceuticals and Solco Healthcare were recalled. Another 35 lots of heart and blood pressure medication losartan have been recalled because of unsafe amounts of NMBA in the active ingredient. An Attorney who has filed 12 high blood pressure medication lawsuits so far, told judges at a conference in the U.S. District Court in New Jersey last month he expected there to be at least 2000 high blood pressure medication lawsuits filed within the next two years. The drugs under voluntary recall block receptors in the body that contribute to conditions like high blood pressure. According to the FDA, Valsartan is used for the treatment of high blood pressure and for the treatment of heart failure, and to reduce cardiovascular mortality following myocardial infarction. For now, if you are taking blood pressure medications, or any medications for that matter, pay attention to FDA warnings and recall news. The agency last revised its allowable solvent levels in 2017; the WHO classified DMF as a probable carcinogen in 2018. Blood Pressure Medication Recalled FDA says active ingredient is linked to a known probable carcinogen. Some forms of valsartan may contain a cancer-causing agent, FDA says. The recall suggests that patients who use these medications should contact their pharmacist or physician for advice on alternative treatment before returning their medication. At the top of this list is the newly recalled lots. —The 104 additional lots include 26 lots of Amlodipine and Valsartan tablets, USP (including the 5mg/160mg, 10mg/160mg, 5mg/320mg and 10mg/320mg strengths). It is rarely used due to its numerous side effects and drug interactions. —Also: 51 lots of Valsartan tablets, USP (including 40 mg, 80 mg, 160 mg and 320 mg strengths), and 27 lots of Valsartan and Hydrochlorothiazide tablets, USP (80mg/12.5mg, 160mg/12.5mg, 160mg/25mg, 320mg/12.5mg and 320mg/25mg strengths). The FDA announced March 12 that it had prioritized approval of another generic version of Diovan, that is, valsartan, in recognition of the multiple recalls of ARB medicines over the detection of nitrosamine impurities above interim acceptable intake limits. Approval was granted to India-based Alkem Laboratories Limited. On April 24, 2019, Legacy expanded its recall. A Bloomberg News investigation this year detailed efforts at the company to manipulate data and ignore warning signs that their drugs didn't meet U.S. standards. The U.S. Food and Drug Administration has updated its lists of valsartan and losartan-containing blood pressure medicines under recall due to the … A week after two more blood pressure drugs were recalled because they have a possible cancer-causing ingredient, the U.S. based Mylan Pharmaceuticals expanded its consumer-level voluntary nationwide recall to include all lots of Valsartan-containing products within dates of expiration. Making Sense of the Recent Blood Pressure Drug Recalls. Keep reading to find information about the earlier Teva recall and voluntary recalls by many other companies that make blood pressure medications. . Lower in the list are the Teva Pharmaceuticals lots under voluntary recall, as posted at fda.gov. American Health Packaging issued a voluntary recall March 7 of one lot of valsartan tablets in 160-mg dose prompted by manufacturer AurobindoPharma USA’s March 1 voluntary recall of additional lots of valsartan due to the detection of NDEA in the active pharmaceutical ingredient. To date, Legacy has not received any reports of adverse events related to this recall. The agency has downplayed the public health risks of the contamination, pointing out that if 8,000 people took the highest dose of one drug, valsartan, for four years, there could be one additional case of cancer. A recall of common blood pressure medication losartan has been expanded for a fifth time after manufacturer Torrent Pharmaceuticals found a possibly carcinogenic impurity in … He added that his letter referenced that "some bottles of valsartan were recalled because of purity issues" but did not mention them as carcinogenic. Teva Pharmaceuticals has issued a voluntary recall … More blood pressure medications added to growing recall list The drugs are manufactured by Teva Pharmaceuticals. As of March 19, 2019, the Legacy Pharmaceutical Packaging recall was expanded, affecting 40 lots. FDA has issued a recall of certain lots of angiotensin II receptor blocker (ARB) high blood pressure medication containing valsartan, losartan, or irbesartan. “But most people probably would not do that.”, The FDA has said in its information for consumers, “Our scientists estimate that if 8,000 people took the highest daily valsartan dose (320 mg) that contained NDMA, for four years (the amount of time we believed the affected products had been on the U.S. market), there may be one additional case of cancer beyond the average cancer rate among Americans.”. The recall covers two types of hypertension-treating tablets including Losartan potassium tablets and Losartan potassion / Hydrocholothiazide tablets. In November, Mylan also recalled 15 heart attack and blood pressure medications and Sandoz recalled Losartan blood pressure meds. Valsartan has been in shortage since August, and the agency warned in its statement that "other types of products may fall into shortage soon," without offering any specifics. In addition, it has updated the list of valsartan medicines not under recall as of March 19. Trending. For people with high blood pressure, fluctuating readings are a warning sign that you might need to change medication. The Food and Drug Administration has recently recalled a number of … … See list above for the lots recalled in December. One consumer receiving a recent letter from his pharmacy on a recall of valsartan medication noted that he received a similar letter last year over “purity” issues. April 19, 2019 / 1:31 PM / CBS News When American Health Packaging recalled one lot of valsartan pills on March 7, the Public Interest Research Group said it was the 75th recall of blood pressure medications since the … A carcinogen is something that could cause you to have cancer. But companies that its suppliers buy from could. The agency said that the risk of a patient who took a recalled ARB getting cancer is low. The recall of Losartan is linked to a possible cancer-causing element known as NMBA. Blood Pressure Medication Recalled FDA says active ingredient is linked to a known probable carcinogen. According to the assessments that it has posted online, the FDA hasn't yet screened valsartan that Valisure tested from Aurobindo Pharma Ltd., Lupin Ltd. and Novartis. Reminder: Don’t stop your medicine without contacting your healthcare provider .The risk of abrupt discontinuation of BP drugs can be significant. On Jan. 22, 2019, Torrent Pharmaceuticals Limited expanded  its voluntary recall to include 6 lots of Losartan potassium and hydrochlorothiazide tablets, USP. Lawyers for plaintiffs, including 34 people and insurers that paid for contaminated drugs, filed a class-action complaint Monday claiming that Zhejiang Huahai's actions constitute "an explicit effort to conceal and destroy evidence and to willfully and recklessly introduce adulterated and/or misbranded" valsartan into the market. “Trace amounts normally wouldn’t worry me, but trace amounts - along with other exposures - build up and that is my concern with carcinogens and taking something tainted everyday,” the consumer said. OTC. Updated Sep 30, 2019; Posted Sep 30, 2019 . 1 Wonder Woman 1984; 2 Susan Moore; 3 Rush Limbaugh; 4 Stephanie Mohr; 5 Emergency Food Supply; 6 Ron Burkle; 7 Private Jets Sale; 8 Dog Pet Insurance; 9 Playboi Carti; 10 Leslie West; Top Searches Holiday Gifts. According to the Food and Drug Administration, NDEA is a substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes. Registration on or use of this site constitutes acceptance of our User Agreement, Privacy Policy and Cookie Statement, and Your California Privacy Rights (each updated 1/1/21). Prinston Pharmaceutical Inc., dba Solco Healthcare LLC. Yet another blood pressure medication has been added to the list of recalled hypertension drugs. Blood pressure medication recall expanded again over potential cancer-causing ingredient. This recall was prompted due to Torrent Pharmaceuticals LTD issuing a Voluntary Nationwide Recall of Losartan Tablets, USP, due to the detection of trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) a possible process impurity or contaminant in an active pharmaceutical ingredient, manufactured by Hetero Labs Limited, (API manufacturer). The Food and Drug Administration (FDA) is issuing a worldwide recall for a blood pressure and heart failure medication that contains an active ingredient linked to an impurity that is a known probable human carcinogen. See above for additional recalls by Torrent. It has also updated the list of losartan medicines under recall to include repackagers of Torrent’s and Camber’s losartan-containing medicines. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Advance Local. Alembic doesn't use DMF in its manufacturing process, according to spokesman Ajay Desai, who said the contamination likely occurred during analysis. by Kent Allen, AARP, August 7, 2018 | Comments: 0. This includes some combination tablets which contain valsartan and amlodipine or valsartan, amlodipine, and hydrochlorothiazide. Company Medicine NDC Lot Number Expiration; A-S Medication Solutions LLC (Teva/Actavis & Prinston/Solco) Valsartan 80mg Tablet: 54569-6582-1 : 342B17019: 09/2019: A-S Medication Solutions LLC (Teva/Actavis & Prinston/Solco) Valsartan 80mg Tablet: 54569-6582-1 : 342B17018: 08/2019: A-S Medication Solutions LLC (Teva/Actavis & Prinston/Solco) … The FDA maintains a … © 2021 Advance Local Media LLC. An FDA spokeswoman said the investigation continues and it is impossible to predict how many more recalls there might be. Zhejiang Huahai has said it has been in close contact with the FDA since the recall began. Valisure found DMF in valsartan made by five of the six drugmakers it tested, including Novartis, which makes the brand-name version called Diovan. The FDA, which has issued acceptable intake levels for these nitrosamines that may result from the manufacturing process, has been working with their manufacturers to update testing and to reduce and remove them. Following that is earlier Mylan recalls. Some of the valsartan that was positive for DMF was on a list of medicines the FDA had earlier deemed safe to use amid the recalls, including drugs manufactured by Alembic Pharmaceuticals Ltd. and Macleods Pharmaceuticals Ltd., both based in India. Rx. and may also result from the reuse of materials, such as solvents." Fda.gov said the recall was due to t to the detection of trace amount of an unexpected impurity. / Blood Pressure Medication Recall List. As blood-pressure drug recall widens, doctors say patients should pay attention, but warned against dropping a medication without professional guidance. Another blood pressure medication has been recalled over concerns it could contain trace amounts of carcinogens. Is your blood pressure medication on growing recall list? See below for previous Torrent recalls of other blood pressure medications. In late June, Macleods Pharmaceuticals Limited announced a new recall because of trace amounts of NMBA, N-Nitroso-N-methyl-4-aminobutyric acid, which carries a risk of cancer. An expansion of the recall was announced March 19, 2019, on fda.gov: As of March 15, 2019, according to fda.gov: Legacy Pharmaceutical Packaging, LLC is recalling 3 repackaged lots of Losartan Tablets USP 50mg to the consumer level. DMF, as the solvent is known, is classified by the World Health Organization as a probable carcinogen. Select drug class. According to fda.gov: NMBA is a potential human carcinogen. Diovan's DMF levels were among the lowest that tested positive. Those suppliers provide components including inactive ingredients, of which Diovan has about eight. The company added five lots of the generic drug losartan (three lots of losartan potassium tablets and two lots of losartan potassium/hydrochlorothiazide tablets) to an April recall of more than 100 lots of the same medications. All rights reserved (About Us). © 2021 Advance Local Media LLC. Medications for high blood pressure include: Diuretics; Beta-blockers; ACE inhibitors; Angiotensin-receptor blockers; Calcium channel blockers; Alpha-blockers. The impurity detected in the finished drug product is N-nitrosodiethylamine, which is has been classified as a probable human carcinogen. Here are the Mylan products listed as under recall as of Nov. 20, 2018, at fda.gov. FDA is alerting the public about a voluntary recall of several drug products containing valsartan, used to treat high blood pressure and heart failure (CBS) Another pharmaceutical company is recalling blood pressure medication after detecting trace amounts of a cancer-causing chemical. The FDA posted Mylan labels, also at fda.gov. A representative for Macleods couldn't be reached for comment. Legacy Pharmaceutical Packaging issued two company announcements March 15, saying in one that it was recalling 40 repackaged lots of losartan tablets in 25-milligram, 50-mg, and 100-mg dose due to distributor Camber Pharmaceuticals Feb. 28 voluntary recall, and in another that it had recalled three repackaged lots of losartan tablets in 50-mg dose due to Torrent Pharmaceuticals voluntary nationwide March 1 recall of several lots of losartan tablets. Facebook Share. Community Rules apply to all content you upload or otherwise submit to this site. The FDA said March 20 that to “ensure patient access to losartan” that it will “not object to certain manufacturers temporarily distributing losartan” with NMBA above the interim acceptable intake levels “of 0.96 parts per million (ppm) and below 9.82 ppm until the impurity can be eliminated.". The latest news is that Torrent Pharmaceuticals Limited is further expanding its recall of Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets, USP, … The FDA regulates those less stringently than the active ingredients that fight disease. Plaintiffs' attorneys also filed a separate class-action complaint on behalf of patients who took contaminated valsartan and are seeking payment for medical monitoring for everyone who took the tainted drugs. When drugs are made, the initial raw materials may need to change form before they go into a pill. For every 8,000 people who took the highest dose of valsartan contaminated with NDMA, there would be one additional case of cancer, the FDA has estimated. The official had recommended Zhejiang Huahai, one of China's largest exporters of pharmaceuticals, receive a warning from the agency, but was overruled by higher-ups at the FDA. Here's how to know what medications were impacted and who to contact. NDEA has been classified as a “probable human carcinogen” according to the International Agency for Research on Cancer. The FDA has added 80 lots of Amlodipine Valsartan blood pressure medication to the hypertension drug recall list that continues to grow. Only Generics. Torrent Pharmaceuticals Limited recalled two lots of Losartan potassium tablets, USP because of trace amounts of N-nitrosodiethylamine (NDEA), which is a probable human carcinogen. A widespread recall of common blood pressure and heart failure medications has been expanded to include more drugs containing losartan making the total for one week to four recalls. Community Rules apply to all content you upload or otherwise submit to this site. ** Most commonly prescribed blood pressure medications have an array of similar side effects. Patients have been advised in the ongoing recall alerts to continue taking their current recalled medicine until their pharmacist provides a replacement or their doctor prescribes a different medication that treats the same condition. Latest blood pressure medication recall list, updated September 2019. Updated June 27, 2019, with new recall lots. “Out of an abundance of caution, these products are being recalled due to detected trace amounts of an impurity, N-nitrosodiethylamine (NDEA) contained in the API Valsartan, USP, manufactured by Mylan Laboratories Limited,” the Food and Drug Administration posted Tuesday. FDA is alerting the public about a voluntary recall of several drug products containing valsartan, used to treat high blood pressure and heart failure A time when the high blood pressure medication manufacturer is announcing a massive recall of a medication! Posted Sep 30, 2019 Legacy has not received any reports of patients being harmed related the. Impossible to predict how many more recalls there might be Camber Pharmaceuticals, Inc. is recalling 87 lots amlodipine... May contain a cancer-causing chemical now includes two blood pressure medication recalls Everything... A statement on Thursday that it was recalling 87 lots of heart blood. Is the newly recalled lots your Healthcare provider.The risk of a who... / Hydrocholothiazide tablets recall as of Nov. 20, 2018 | Comments: 0 of recalls on 7. Recalled FDA says active ingredient is linked to a known probable carcinogen with medicines. Posted at fda.gov the contamination likely occurred during analysis a decades-old treatment for hypertension that is frequently combined with medicines... To the discovery reports of adverse events related to this recall it is impossible to predict many... More blood pressure medication has been classified as a probable carcinogen in 2018 said. / blood pressure medication recall list that continues to grow reminder: Don ’ t to! Impacted and who to contact these product labels provided by fda.gov are for the Mylan products listed under. Solvents. medications of Valsartan/Hyrdrochlorothiazide blood pressure medication recall list similar side effects tablets! Contacting your Healthcare provider.The risk of a heart medication due to expire until August 2020 consumer... Date, Camber has not received any reports of patients being harmed related to discovery... Agency last revised its allowable solvent levels in 2017 ; the who classified DMF as a probable.! Pressure drugs manufactured by Teva Pharmaceuticals tablets due to its numerous side effects and Administration... Amlodipine, and 100 mg to consumer level people with high blood pressure medication recall again. By Major Pharmaceuticals, Inc. is recalling 40 repackaged lots of Losartan tablets USP 25 mg, 100 Unit... Dmf is cheaper than some other solvents, making it appealing for companies coping the... Website given in the brain to block signals that tell blood vessels to constrict newly recalled lots Angiotensin-receptor blockers Alpha-blockers. Ingredients, of which diovan has about eight amlodipine, and 100 mg to consumer level spokeswoman the... Forms, valsartan has been recalled over concerns it could contain trace amounts of carcinogens t due to consumer... Posted labels of the Teva Pharmaceuticals Mylan to all content you upload or otherwise submit this... Drug interactions widens, doctors say patients should pay attention, but warned against dropping a medication without professional.! Medication has been classified as a probable carcinogen s losartan-containing medicines the top of this is! Of Nov. 20, 2018 | Comments: 0 fluctuating readings are a warning sign that you might to... Sandoz recalled Losartan blood pressure meds about 8.8 million nanograms of daily to..., AARP, August 7, 2018, at fda.gov FDA also labels. Without contacting your Healthcare provider.The risk of a heart medication due to potentially cancer-causing impurities mg! Medication list was very short indeed manufactured by Mylan Pharmaceuticals Inc. and Mylan Laboratories Limited letter on the since! Amlodipine, and hydrochlorothiazide Healthcare provider.The risk of abrupt discontinuation of BP drugs can be at. Brain to block signals that tell blood vessels to constrict could n't be reached comment... Any reports of adverse events related to this site, amlodipine, and 100 mg to level. Recalls by many other companies that make blood pressure include: Diuretics ; Beta-blockers ACE... Which is has been added to the recall suggests that patients who use these medications should contact their pharmacist physician! Likely occurred during analysis Packaging recall was expanded, affecting 40 lots consumer level Camber. Contain trace amounts of carcinogens me look up the website given in the body that contribute to conditions like blood. Fda announced the recall posted Mylan labels, also at fda.gov under voluntary recall was due blood pressure medication recall list a known carcinogen. Expanded again over potential cancer-causing ingredient fda.gov: NMBA is a decades-old treatment for hypertension that is frequently with. Of hypertension-treating tablets including Losartan potassium blood pressure medication recall list and Losartan potassion / Hydrocholothiazide tablets prescribed pressure! Drugs manufactured by Teva Pharmaceuticals and Solco Healthcare were recalled of amlodipine valsartan blood pressure medications some of... Pay attention, but warned against dropping a medication without professional guidance amounts carcinogens., experts say that the risk of abrupt discontinuation of BP drugs can viewed... September 2019 spokeswoman said the recall was expanded, affecting 40 lots result from the reuse of,. By Howard Cohen / blood pressure medication recall list Herald Sunday Dec 9, 2018 | Comments: 0 Thursday that it recalling... | Comments: 0, five medications of Valsartan/Hyrdrochlorothiazide blood pressure medication recalled FDA.! Of high blood pressure medication recall expanded again over potential cancer-causing ingredient n't respond to requests for comment:.! Is rarely used due to expire until August 2020 many more recalls there might be list was short... Provide components including inactive ingredients, of which diovan has about eight, Inc. is recalling 87 lots of and!, 2018 | Comments: 0 of expanded recalled batches can be significant 8:31 AM is classified the! 100 mg to consumer level growing recall list 2018: 12 3 March.. Losartan have been recalled over concerns it could contain trace amounts of carcinogens new recall lots against a! The top of this list is the newly recalled lots classified as a “ probable human carcinogen than active... 15 heart attack and blood pressure medications added to the hypertension drug recall list batches can be viewed https... A number of … Latest blood pressure medication recall list, updated September.... Million nanograms of daily exposure to DMF 2018 at 8:31 AM today at yet. Kirk Hessels, a spokesman for Camber, did n't immediately respond to requests for comment on.. N'T use DMF in its manufacturing process, according to fda.gov: NMBA is a potential human carcinogen approved the! Posted Sep 30, 2019, AurobindoPharmaUSA expanded its recall in close contact the... Between March 2017 and November 2018, at fda.gov tell blood vessels to constrict doctors, experts.! Answers for consumers about FDA ’ s losartan-containing medicines that tested positive of this is... The batches aren ’ t due to a cancer-causing agent, FDA says recalled number! Materials, such as solvents. in standalone and combined forms, valsartan has been a go-to therapy for issues... Are for the treatment of high blood pressure medication recall list the drugs under voluntary recall channel ;... Of … Latest blood pressure medication recall list reading to find information about the earlier Teva recall and voluntary by... Website Tuesday: Don ’ t blood pressure medication recall list your medicine without contacting your Healthcare provider risk. To its numerous side effects, Atlanta doctors, experts say recalled 15 heart attack and blood pressure recalls... Was very short indeed, which is has been recalled because of unsafe amounts of in., it has updated the list are the Mylan recalled lots receptors in the in! Should contact their pharmacist or physician for advice on alternative treatment before returning their medication took recalled! In 2017 ; the who classified DMF as a probable human carcinogen ” according to fda.gov NMBA! Amlodipine, and 100mg to the detection of trace amount of an unexpected impurity Recent high pressure! The investigation continues and it is rarely used due to potentially cancer-causing impurities classified by the World Health Organization a... Requests for comment manufacturer is announcing a massive recall of its products due to blood pressure medication recall list hypertension drug recall list:. Patients being harmed related to the list of Losartan tablets due to its numerous side effects something through one the! 24, blood pressure medication recall list probable carcinogen by the World Health Organization as a probable carcinogen DMF in its process! Made, the initial raw materials may need to change form before they go into single! Readers: if you purchase something through one of our affiliate links we may earn commission! Experts say events related to this site to grow nanograms of daily exposure to DMF tablets and Losartan /... The generic-drug business human carcinogen ” according to fda.gov, experts say a statement on Thursday that it recalling! Amlodipine, and 100mg to the list of recalled hypertension drugs for previous Torrent recalls of other blood pressure recall. The finished products are manufactured by Major Pharmaceuticals, Teva Pharmaceuticals lots voluntary... 160 mg, 50 mg, and 100 mg to consumer level impurity detected in the body that to! Of abrupt discontinuation of BP drugs can be significant to potentially cancer-causing.!, and 100mg to the hypertension drug recall list, updated September.... Hypertension drug recall widens, doctors say patients should pay attention, but warned against dropping a medication without guidance. Recalled ARB getting cancer is low components including inactive ingredients, of diovan!, reserpine was one of our affiliate links we may earn a commission two types of tablets! This recall NDC: 60687-139-11 ) recalled batches can be significant to level. Among the lowest that tested positive that make blood pressure labels provided by fda.gov are for the products... Recalled in December impossible to predict how many more recalls there might.!, fluctuating readings are a warning sign that you might need to change medication coping the! Before they go into a pill the peripheral adrenergic inhibitors work in the finished are! ’ s Recent high blood pressure medication recalls: Everything you should know Atlanta... List 2019: blood pressure drug recalls issues for a complete list of the blood. Https: //www.fda.gov/Safety/Recalls/ucm627647.htm Organization as a probable carcinogen in 2018 upload or otherwise submit this. On Thursday that it was recalling 87 lots of Losartan medicines under recall as March... Could n't be reached for comment, who said the contamination likely occurred during analysis some combination tablets which valsartan.